BCTX BriaCell Therapeutics Corp. - Common Shares
NASDAQ · Biotechnology · View on SEC EDGAR ↗ 10-K/10-Q Dec 11, 2025BCTX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
BCTX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
| Ex-date | Split | Type |
|---|---|---|
| Aug. 25, 2025 | 1-for-10 | Reverse |
| Jan. 2, 2020 | 1-for-300 | Reverse |
| Dec. 3, 2014 | 1-for-3 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Not enough fundamentals data to compute this ratio group yet.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
Not enough fundamentals data to compute this ratio group yet.
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| March 31, 2026 | $-2.58 | $-4.89 | 47.2% | |
| Sept. 30, 2025 | $-55.49 | $-12.23 | -353.7% | |
| June 30, 2025 | $-16.40 | $-17.78 | 7.7% | |
| March 31, 2025 | $-23.30 | $-19.59 | -18.9% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2021 |
|---|---|---|
| R&D Expense | $1M | |
| SG&A Expense | $4M | |
| Operating Income | $-7M | |
| Interest Expense | $46.1K | |
| Interest Income | $3.1K | |
| Net Income | $-428.3K | |
| Shares (Diluted) | 4,519,579 | |
| EBITDA | $-7M |
Balance Sheet
| Metric | Trend | 2021 |
|---|---|---|
| Cash & Equivalents | $57M | |
| Receivables | $12.6K | |
| Current Assets | $58M | |
| Intangibles | $245.6K | |
| Total Assets | $58M | |
| Accounts Payable | $556.8K | |
| Current Liabilities | $556.8K | |
| Retained Earnings | $-16M | |
| Stockholders' Equity | $57M |
Cash Flow
| Metric | Trend | 2021 |
|---|---|---|
| D&A | $15.3K | |
| Other Non-cash | $-7M | |
| Operating Cash Flow | $-8M | |
| Financing Cash Flow | $65M |
Profitability
| Metric | Trend | 2021 |
|---|---|---|
| ROA | -1.5% | |
| ROE | -1.6% |
Liquidity & Solvency
| Metric | Trend | 2021 |
|---|---|---|
| Current Ratio | 103.8 | |
| Quick Ratio | 102.9 | |
| Interest Coverage | -151.3 |
Per Share
| Metric | Trend | 2021 |
|---|---|---|
| Cash Flow / Share | $-1.71 |
Valuation (TTM)
| Metric | Trend | 2021 |
|---|---|---|
| Net Income TTM | $-14M |
Per Share
| Metric | Trend | Q4 2025 | Q4 2021 |
|---|---|---|---|
| EPS (TTM) | $-48.65 | · |
Valuation (TTM)
| Metric | Trend | Q4 2025 | Q4 2021 |
|---|---|---|---|
| Net Income TTM | $-29M | $-14M | |
| P/E | -0.2 | · | |
| Earnings Yield | -442.3% | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2021-07-31 | 2020-07-31 | 2019-08-01 | 2019-07-31 |
|---|---|---|---|---|
| Net Income | $-428.3K | $-4M | $-6M | $-5M |
| Metric | 2021-07-31 | 2020-07-31 | 2019-08-01 | 2019-07-31 |
|---|---|---|---|---|
| Current Ratio | 103.8 | · | · | · |
| Quick Ratio | 102.9 | · | · | · |
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 19 filers · $1.6M total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 5 (-1 vs prior Q) | 0 (-3 vs prior Q) | 5 (+4 vs prior Q) | 2 (-1 vs prior Q) | +125K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Cable Car Capital, LP | $702,500 | 216,821 | 45.24% | Shares |
| IRIDIAN ASSET MANAGEMENT LLC/CT | $278,200 | 65,000 | 17.92% | Shares |
| SABBY MANAGEMENT, LLC | $261,536 | 80,721 | 16.84% | Shares |
| UBS Group AG | $141,400 | 43,642 | 9.11% | Shares |
| JANE STREET GROUP, LLC | $85,909 | 26,515 | 5.53% | Shares |
| LuminArx Capital Management LP | $48,600 | 15,000 | 3.13% | Shares |
| LuminArx Capital Management LP | $22,250 | 25,000 | 1.43% | Call option |
| NATIONAL BANK OF CANADA /FI/ | $5,796 | 1,803 | 0.37% | Shares |
| MORGAN STANLEY | $3,347 | 1,033 | 0.22% | Shares |
| Federation des caisses Desjardins du Quebec | $1,444 | 450 | 0.09% | Shares |
| ROYAL BANK OF CANADA | $1,000 | 289 | 0.06% | Shares |
| Allworth Financial LP | $324 | 100 | 0.02% | Shares |
| SSA SWISS ADVISORS AG | $121 | 37 | 0.01% | Shares |
| HRT FINANCIAL LP | $113 | 34,904 | 0.01% | Shares |
| Caitong International Asset Management Co., Ltd | $110 | 34 | 0.01% | Shares |
| TD Waterhouse Canada Inc. | $78 | 19 | 0.01% | Shares |
| GROUP ONE TRADING LLC | $52 | 16 | 0.00% | Shares |
| HHM Wealth Advisors, LLC | $20 | 6 | 0.00% | Shares |
| WELLS FARGO & COMPANY/MN | $3 | 1 | 0.00% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Marc Lustig, L5 Capital Inc. ×4 filings | Dec. 12, 2024 | · | Initial filing | Passive investment | SEC |
| Ault Global Holdings, Inc. ×2 filings | Sept. 20, 2021 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 3 insiders · 2 officers · 3 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Williams V. Williams | President, CEO | Dec. 23, 2022 P | · | 0 | 0 | $0 |
| Jamieson Bondarenko | Chairman | Dec. 28, 2022 P | 169,856 | 0 | 0 | $0 |
| Marc Lustig | Director | May 14, 2024 P | 2,542,935 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
BCTX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.